Convalescent Plasma News and Research

RSS
Severe symptoms result in high titers of SARS-CoV-2 antibodies

Severe symptoms result in high titers of SARS-CoV-2 antibodies

Benefit from convalescent plasma shown in COVID outpatient trial

Benefit from convalescent plasma shown in COVID outpatient trial

Outcomes of COVID-19 treatment with Paxlovid

Outcomes of COVID-19 treatment with Paxlovid

The war against COVID-19: reinfection, vaccines, and herd immunity

The war against COVID-19: reinfection, vaccines, and herd immunity

Phase 2 clinical trial of COVID-19 convalescent plasma with high antibody titers

Phase 2 clinical trial of COVID-19 convalescent plasma with high antibody titers

Findings of the HITCH randomized clinical trial show lack of improvement in COVID-19 on temporary androgen suppression

Findings of the HITCH randomized clinical trial show lack of improvement in COVID-19 on temporary androgen suppression

Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

Waning antibody responses in SARS-CoV-2-infected children and adults over time

Waning antibody responses in SARS-CoV-2-infected children and adults over time

New, longest documented case of persistent acute SARS-CoV-2 infection

New, longest documented case of persistent acute SARS-CoV-2 infection

Efficacy of SARS-CoV-2 hyperimmune globulin in treatment of severely immunocompromised hospitalized COVID-19 patients

Efficacy of SARS-CoV-2 hyperimmune globulin in treatment of severely immunocompromised hospitalized COVID-19 patients

Does COVID-19 vaccination benefit those with prior SARS-CoV-2 infection?

Does COVID-19 vaccination benefit those with prior SARS-CoV-2 infection?

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

How the timing and dose of different types of passive antibody treatments predict protection from SARS-CoV-2 infection

How the timing and dose of different types of passive antibody treatments predict protection from SARS-CoV-2 infection

Detection of immune and clotting dysfunction in plasma and saliva after SARS-CoV-2 infection

Detection of immune and clotting dysfunction in plasma and saliva after SARS-CoV-2 infection

Research characterizes efficacy of various COVID vaccines against Omicron BA.1 and BA.2

Research characterizes efficacy of various COVID vaccines against Omicron BA.1 and BA.2

Convalescent antibodies do not enhance SARS-CoV-2 infection

Convalescent antibodies do not enhance SARS-CoV-2 infection

Study shows the mutations leading to omicron variant did not help virus escape recognition by T cells

Study shows the mutations leading to omicron variant did not help virus escape recognition by T cells

Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient